Related Experiment Video
Updated: Jun 3, 2025

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage
Published on: January 31, 2018
PARP-1 Inhibition Increases Oxidative Stress in Ets-1-Expressing MDA-MB-231 Breast Cancer Cells.
Magalie Hervieu1,2, Arnaud J Legrand1,2, Emilie Floquet1,2
1CNRS EMR9002 Integrative Structural Biology, Lille, France.
Poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors reduce breast cancer cell growth by increasing oxidative stress and DNA damage, particularly in Ets-1-expressing cells. This mechanism highlights a targeted approach for cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Ets-1 transcription factor is crucial in cancer progression.
- Poly(ADP-ribose) polymerase-1 (PARP-1) inhibition increases Ets-1 levels, leading to cancer cell death.
Purpose of the Study:
- Investigate the antitumor mechanism of PARP-1 inhibition in Ets-1-expressing breast cancer cells.
- Elucidate the role of Ets-1 in PARP-1 inhibitor-induced cellular effects.
Main Methods:
- Tested four PARP inhibitors (PJ-34, Veliparib, Olaparib, Rucaparib).
- Assessed cell growth, cell cycle arrest (G2/M phase).
- Evaluated oxidative DNA damage, reactive oxygen species (ROS) production, and p47phox expression in Ets-1-overexpressing vs. non-expressing cells.
Main Results:
- PARP inhibitors reduced cell growth via G2/M cell cycle arrest.
- PARP inhibitors induced oxidative DNA damage and triggered DNA damage response specifically in Ets-1-overexpressing cells.
- PARP inhibitors increased ROS and p47phox expression in Ets-1-overexpressing cells.
Conclusions:
- PARP-1 inhibition-induced oxidative DNA damage and oxidative stress are correlated with Ets-1 expression in breast cancer cells.
- Findings suggest a potential therapeutic strategy targeting Ets-1-expressing cancers.
More Related Videos
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
PI3K/mTOR/AKT Signaling Pathway

